1. What is the projected Compound Annual Growth Rate (CAGR) of the Knockout Mouse Models?
The projected CAGR is approximately XX%.
MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.
Knockout Mouse Models by Type (KO, cKO, World Knockout Mouse Models Production ), by Application (Metabolic Disease Mouse Models, Neurodegenerative Disease Mouse Models, Rare Disease Mouse Models, Spontaneous Tumor Mouse Models, Other), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast 2025-2033
The global knockout mouse models market is experiencing robust growth, driven by the increasing demand for preclinical research models in drug discovery and development. The market's expansion is fueled by advancements in gene editing technologies like CRISPR-Cas9, enabling more efficient and cost-effective generation of knockout mouse models. This increased efficiency translates to wider accessibility for researchers across various fields, including pharmaceutical companies, biotechnology firms, and academic institutions. Significant growth is observed across applications such as metabolic disease, neurodegenerative disease, and rare disease research. The availability of sophisticated knockout models allows for a more precise understanding of disease mechanisms and facilitates the development of targeted therapies. While the exact market size in 2025 is unavailable, considering a conservative CAGR of 10% from a 2019 base of $500 million (a reasonable estimate based on market reports for related segments), the market size in 2025 could be conservatively estimated at $732 million.
The market is segmented by model type (KO, cKO, and whole-body knockout), reflecting varying research needs and experimental designs. Regional variations exist, with North America and Europe currently dominating due to the concentration of major pharmaceutical and biotechnology companies and well-established research infrastructures. However, Asia-Pacific is anticipated to demonstrate significant growth in the coming years, driven by rising research funding and a growing focus on translational research. Competitive landscape features established players such as The Jackson Laboratory, Charles River Laboratories, and Taconic Biosciences, along with emerging companies specializing in specific knockout models or niche applications. Challenges include the high cost of generating and maintaining knockout mouse models, ethical considerations surrounding animal research, and the potential for off-target effects of gene editing technologies. Despite these restraints, the market's future prospects remain positive, driven by continued technological advancements, increasing research funding, and the urgent need for effective disease treatments.
The global knockout mouse models market is experiencing robust growth, projected to reach multi-million unit sales by 2033. Driven by advancements in gene editing technologies like CRISPR-Cas9, the market witnessed a significant upswing during the historical period (2019-2024), with an estimated value of XXX million units in 2025. This growth is fueled by the increasing demand for preclinical research models across various therapeutic areas, including oncology, metabolic disorders, and neurodegenerative diseases. The market is characterized by a diverse range of players, from large multinational companies like Charles River Laboratories and Taconic Biosciences to specialized research institutions like The Jackson Laboratory. The availability of a wide spectrum of knockout mouse models, encompassing conditional knockouts (cKO) and traditional knockouts (KO), further broadens the market's appeal. While traditional KO models remain prevalent, the growing sophistication of cKO models, allowing for tissue-specific gene deletion, is driving segment-specific growth. This trend signifies a shift towards more precise and nuanced research capabilities, enhancing the translational relevance of preclinical studies. The increasing adoption of contract research organizations (CROs) for the development and supply of knockout mouse models further contributes to market expansion. The forecast period (2025-2033) anticipates continued expansion, driven by factors such as increasing research funding in biomedical sciences and the rising prevalence of chronic diseases necessitating advanced preclinical research.
Several factors are propelling the growth of the knockout mouse models market. Firstly, the continuous advancement in gene editing technologies, particularly CRISPR-Cas9, has significantly reduced the cost and time required to generate knockout mouse models. This has made them more accessible to a broader range of researchers, leading to increased adoption. Secondly, the growing need for robust and reliable preclinical models to study human diseases is a significant driver. Knockout mouse models provide a powerful tool to understand disease mechanisms and evaluate the efficacy of novel therapeutic interventions. The rising prevalence of chronic diseases, such as cancer, diabetes, and neurodegenerative disorders, is further fueling the demand for these models. Thirdly, increased research funding in the biomedical sector, coupled with greater government and private investment in drug discovery and development, is providing substantial impetus to the market. Finally, the emergence of sophisticated conditional knockout models allows for more targeted and controlled gene manipulation, enhancing the translational value of the research and consequently driving demand. This, alongside the growing adoption of these models by CROs, which enhances the accessibility and affordability for research institutions and biotech companies, creates a positive feedback loop for growth.
Despite the significant growth potential, the knockout mouse models market faces certain challenges. The high cost associated with generating and maintaining these models can be a barrier to entry for smaller research institutions and laboratories. Furthermore, the ethical considerations surrounding animal research, including regulations and welfare concerns, continue to impact market growth. The complexity of interpreting data from knockout mouse models, and the potential for off-target effects of gene editing technologies, present significant hurdles. The variability in the phenotype of knockout mice, even within the same genetic background, can also affect the reproducibility of research findings, creating difficulties for researchers looking for reliable data. Finally, the long lead times required for generating and validating knockout mouse models, combined with the need for specialized expertise and infrastructure, can limit the speed of research. These factors can hinder widespread adoption and limit the pace of market growth.
The North American market is projected to dominate the global knockout mouse models market throughout the forecast period (2025-2033), driven by significant investments in biomedical research, the presence of major players like The Jackson Laboratory and Charles River Laboratories, and strong regulatory frameworks supporting preclinical research. Europe is also expected to hold a substantial market share, with strong research infrastructure and growing collaborations between academia and industry.
The high cost of developing and maintaining knockout mouse models necessitates high upfront investment, pushing larger research institutions and pharmaceutical companies towards these models. This trend further supports the market’s dominance within developed regions possessing the financial resources to support such efforts.
The increasing prevalence of chronic diseases worldwide, coupled with advancements in gene editing technologies and the rising adoption of contract research organizations (CROs) for outsourcing model development, significantly contribute to the growth of the knockout mouse models market. These factors, combined with robust government and private investment in biomedical research, provide strong impetus for market expansion in the coming years.
This report provides a comprehensive overview of the knockout mouse models market, covering market size, trends, drivers, challenges, and leading players. The report includes detailed analysis of key segments, including different types of knockout models (KO, cKO) and applications across various therapeutic areas. The extensive market forecast, spanning from 2025 to 2033, provides valuable insights into future market dynamics and growth opportunities. The report also highlights recent significant developments and key players' strategies, offering a holistic perspective on the current state and future trajectory of this crucial sector within the biomedical research landscape.
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of XX% from 2019-2033 |
| Segmentation |
|




Note*: In applicable scenarios
Primary Research
Secondary Research

Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
The projected CAGR is approximately XX%.
Key companies in the market include The Jackson Laboratory, Charles River Laboratories, Taconic Biosciences, Envigo, Janvier Labs, GemPharmatech, GenOway, Applied StemCell, Fred Hutch, Mary Lyon Centre.
The market segments include Type, Application.
The market size is estimated to be USD XXX million as of 2022.
N/A
N/A
N/A
N/A
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4480.00, USD 6720.00, and USD 8960.00 respectively.
The market size is provided in terms of value, measured in million and volume, measured in K.
Yes, the market keyword associated with the report is "Knockout Mouse Models," which aids in identifying and referencing the specific market segment covered.
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
To stay informed about further developments, trends, and reports in the Knockout Mouse Models, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.